Noseguard for Prevention of Respiratory Infections in Real-World Use

Sponsor
Daewoong Pharmaceutical Co. LTD.
Study ID
NCT07516977
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • COVID-19
  • Influenza
  • Respiratory Infection Virus

Eligibility Criteria

Sex
ALL
Age
19 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Noseguard and Noseguard Night — DEVICE
    Nasal spray medical devices used to form a protective barrier on the nasal mucosa to reduce viral entry.

Study Details

This study is a prospective clinical study to evaluate the effectiveness of combined use of two nasal protective medical devices (Noseguard and Noseguard Night) in reducing respiratory infection rates, including COVID-19 and influenza, in real-world conditions. The study will also assess usability, satisfaction, and safety using electronic patient-reported outcomes (ePRO).

Key Dates

First listed
Apr 8, 2026
Start date
Apr 20, 2026
Status verified
Apr 2026
Primary completion
Aug 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
2,000 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION

Arms

  • Experimental: Noseguard Combined Use
    Participants will use Noseguard during daytime activities and Noseguard Night before sleep for 8 weeks.

Primary Outcome Measure

Incidence of Respiratory Infection [ Time Frame: Week 8 ]

Central Contacts

Find similar trials

Nationwide
COVID-19 / long COVID trialsInfectious disease trials

Related Studies